A Multi-center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion

This phase I trial reports the first use of intra arterial temozolomide via isolated limb infusion for patients with advanced extremity melanoma. There was minimal toxicity and the maximum tolerated dose was determined.

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Beasley, Georgia M., Speicher, Paul, Augustine, Christina K., Dolber, Paul C., Peterson, Bercedis L., Sharma, Ketan, Mosca, Paul J., Royal, Richard, Ross, Merrick, Zager, Jonathan S., Tyler, Douglas S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4464816/
https://ncbi.nlm.nih.gov/pubmed/25145500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-3887-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados